Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ventricular Remodeling | 15 | 2024 | 1282 | 2.020 |
Why?
|
Myocardial Perfusion Imaging | 7 | 2024 | 672 | 2.000 |
Why?
|
Magnetic Resonance Imaging, Cine | 25 | 2024 | 1092 | 1.940 |
Why?
|
Myocardial Ischemia | 8 | 2024 | 2139 | 1.300 |
Why?
|
Myocardial Infarction | 17 | 2024 | 11521 | 1.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2024 | 1335 | 1.000 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2024 | 1399 | 0.870 |
Why?
|
Coronary Circulation | 7 | 2024 | 1617 | 0.780 |
Why?
|
Coronary Artery Disease | 13 | 2024 | 6569 | 0.740 |
Why?
|
Fibrosis | 11 | 2024 | 2080 | 0.640 |
Why?
|
Predictive Value of Tests | 22 | 2024 | 15471 | 0.610 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36854 | 0.600 |
Why?
|
Contrast Media | 12 | 2022 | 5334 | 0.580 |
Why?
|
Ventricular Function, Left | 14 | 2024 | 3941 | 0.560 |
Why?
|
Esters | 1 | 2017 | 212 | 0.510 |
Why?
|
Exercise Test | 5 | 2024 | 2187 | 0.490 |
Why?
|
Cardiac Imaging Techniques | 2 | 2014 | 280 | 0.470 |
Why?
|
Myocardium | 10 | 2024 | 4790 | 0.460 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2034 | 0.460 |
Why?
|
Heart Ventricles | 6 | 2017 | 3840 | 0.450 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2024 | 3411 | 0.350 |
Why?
|
Cardiomyopathies | 6 | 2023 | 2057 | 0.340 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2022 | 843 | 0.340 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 877 | 0.310 |
Why?
|
Prognosis | 20 | 2024 | 30046 | 0.310 |
Why?
|
Registries | 7 | 2024 | 8384 | 0.300 |
Why?
|
Heart Failure | 6 | 2024 | 11879 | 0.300 |
Why?
|
Atrial Function, Left | 3 | 2019 | 188 | 0.290 |
Why?
|
Stroke Volume | 11 | 2022 | 5622 | 0.290 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2020 | 856 | 0.290 |
Why?
|
Phenotype | 3 | 2024 | 16731 | 0.280 |
Why?
|
Gadolinium | 4 | 2022 | 965 | 0.280 |
Why?
|
Risk Assessment | 12 | 2024 | 24333 | 0.270 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2013 | 1724 | 0.270 |
Why?
|
Image Enhancement | 4 | 2022 | 2898 | 0.270 |
Why?
|
Heart Septum | 2 | 2017 | 304 | 0.250 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 560 | 0.250 |
Why?
|
Coronary Stenosis | 1 | 2011 | 802 | 0.250 |
Why?
|
Gadolinium DTPA | 4 | 2016 | 823 | 0.240 |
Why?
|
Hypertension | 1 | 2024 | 8617 | 0.230 |
Why?
|
Coronary Angiography | 2 | 2017 | 4541 | 0.230 |
Why?
|
Myocarditis | 2 | 2023 | 803 | 0.220 |
Why?
|
Death, Sudden, Cardiac | 5 | 2024 | 1568 | 0.220 |
Why?
|
Fish Oils | 2 | 2018 | 483 | 0.220 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1526 | 0.210 |
Why?
|
Radiation Dosage | 1 | 2011 | 1970 | 0.210 |
Why?
|
Heart Diseases | 1 | 2015 | 2819 | 0.190 |
Why?
|
Humans | 66 | 2024 | 768970 | 0.190 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 325 | 0.190 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2017 | 2145 | 0.180 |
Why?
|
Perfusion | 2 | 2023 | 1402 | 0.180 |
Why?
|
Heart Atria | 2 | 2019 | 1361 | 0.180 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.180 |
Why?
|
Eicosapentaenoic Acid | 2 | 2024 | 565 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4076 | 0.170 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 102 | 0.160 |
Why?
|
Female | 45 | 2024 | 397515 | 0.160 |
Why?
|
Male | 43 | 2024 | 365203 | 0.150 |
Why?
|
Vasodilator Agents | 2 | 2014 | 990 | 0.150 |
Why?
|
Electrocardiography | 4 | 2024 | 6413 | 0.150 |
Why?
|
Heart Injuries | 1 | 2020 | 207 | 0.150 |
Why?
|
Middle Aged | 36 | 2024 | 223737 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3538 | 0.140 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5892 | 0.140 |
Why?
|
Systole | 2 | 2017 | 937 | 0.140 |
Why?
|
Prospective Studies | 13 | 2024 | 54962 | 0.140 |
Why?
|
Aged | 29 | 2024 | 171786 | 0.140 |
Why?
|
Atrial Fibrillation | 4 | 2019 | 5176 | 0.130 |
Why?
|
Echocardiography, Doppler | 2 | 2017 | 898 | 0.130 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 262 | 0.120 |
Why?
|
Reproducibility of Results | 9 | 2024 | 20245 | 0.120 |
Why?
|
Algorithms | 2 | 2019 | 14201 | 0.120 |
Why?
|
Adiponectin | 1 | 2019 | 1117 | 0.110 |
Why?
|
Chest Pain | 1 | 2021 | 1101 | 0.110 |
Why?
|
Myocardial Revascularization | 1 | 2017 | 796 | 0.110 |
Why?
|
Risk Factors | 17 | 2024 | 74976 | 0.110 |
Why?
|
Nausea | 1 | 2016 | 682 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2013 | 197 | 0.110 |
Why?
|
Insulin Resistance | 2 | 2019 | 3982 | 0.100 |
Why?
|
Observer Variation | 5 | 2017 | 2623 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 914 | 0.100 |
Why?
|
Heart | 3 | 2021 | 4447 | 0.100 |
Why?
|
Cicatrix | 2 | 2020 | 799 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3968 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1030 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2046 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 615 | 0.100 |
Why?
|
Leptin | 1 | 2019 | 1597 | 0.090 |
Why?
|
Primary Prevention | 1 | 2019 | 1187 | 0.090 |
Why?
|
Troponin T | 1 | 2016 | 787 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20776 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1447 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15951 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2017 | 644 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2194 | 0.090 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2015 | 346 | 0.090 |
Why?
|
Anthracyclines | 1 | 2012 | 286 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2013 | 312 | 0.090 |
Why?
|
Sarcomeres | 1 | 2013 | 380 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1739 | 0.090 |
Why?
|
Erythrocytes | 1 | 2019 | 2421 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39394 | 0.080 |
Why?
|
Fibroblasts | 1 | 2020 | 4179 | 0.080 |
Why?
|
Aortic Valve | 1 | 2019 | 1969 | 0.080 |
Why?
|
Postmenopause | 1 | 2018 | 2519 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2258 | 0.080 |
Why?
|
Double-Blind Method | 3 | 2019 | 12467 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 65480 | 0.080 |
Why?
|
Coronary Vessels | 2 | 2024 | 3124 | 0.080 |
Why?
|
Tomography, Emission-Computed | 1 | 2012 | 1126 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1475 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 544 | 0.080 |
Why?
|
Uncertainty | 2 | 2024 | 769 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3782 | 0.070 |
Why?
|
Pulmonary Veins | 1 | 2013 | 758 | 0.070 |
Why?
|
Amyloidosis | 1 | 2015 | 879 | 0.070 |
Why?
|
Obesity | 3 | 2014 | 13091 | 0.070 |
Why?
|
Time Factors | 7 | 2024 | 40261 | 0.070 |
Why?
|
Disease Progression | 7 | 2019 | 13674 | 0.070 |
Why?
|
Medicare | 1 | 2024 | 6888 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 984 | 0.060 |
Why?
|
Adult | 16 | 2024 | 223851 | 0.060 |
Why?
|
Organometallic Compounds | 2 | 2019 | 648 | 0.060 |
Why?
|
Patient Selection | 2 | 2017 | 4265 | 0.060 |
Why?
|
Defibrillators, Implantable | 3 | 2019 | 1498 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2013 | 2780 | 0.050 |
Why?
|
United States | 4 | 2024 | 73186 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9499 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2019 | 9080 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 81903 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14752 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 12562 | 0.050 |
Why?
|
Extracellular Space | 2 | 2013 | 565 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2017 | 5323 | 0.040 |
Why?
|
Lewy Body Disease | 1 | 2003 | 253 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2024 | 893 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6547 | 0.040 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2019 | 110 | 0.040 |
Why?
|
Proinsulin | 1 | 2019 | 135 | 0.040 |
Why?
|
Alberta | 1 | 2019 | 67 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2019 | 22296 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 5047 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59739 | 0.040 |
Why?
|
Rodentia | 1 | 2020 | 262 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2130 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2019 | 158 | 0.040 |
Why?
|
ROC Curve | 2 | 2017 | 3629 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 429 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 443 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2013 | 3431 | 0.030 |
Why?
|
Age Factors | 3 | 2024 | 18435 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10868 | 0.030 |
Why?
|
Reference Values | 2 | 2014 | 4940 | 0.030 |
Why?
|
Hemodynamics | 2 | 2019 | 4199 | 0.030 |
Why?
|
Pilot Projects | 2 | 2024 | 8748 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10633 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6856 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8745 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 208 | 0.030 |
Why?
|
Electric Countershock | 1 | 2016 | 534 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2537 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41808 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2020 | 951 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1112 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1701 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1645 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4251 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15661 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 848 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 520 | 0.020 |
Why?
|
Body Mass Index | 3 | 2014 | 13055 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2360 | 0.020 |
Why?
|
Health Care Costs | 1 | 2024 | 3270 | 0.020 |
Why?
|
Genetic Testing | 1 | 2024 | 3591 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1586 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12095 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1292 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2018 | 1682 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2003 | 2895 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7245 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30266 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 60131 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3628 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8055 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21547 | 0.020 |
Why?
|
Prevalence | 2 | 2014 | 15879 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2019 | 3443 | 0.020 |
Why?
|
Equipment Design | 1 | 2014 | 3530 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15604 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9618 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2464 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2646 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1890 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4124 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6236 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23786 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22389 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2003 | 41 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12174 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 89244 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3811 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3859 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8894 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9684 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8513 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4860 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5544 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12873 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16053 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9384 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13021 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6435 | 0.010 |
Why?
|
Homozygote | 1 | 2003 | 1780 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13318 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26395 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2013 | 18068 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14794 | 0.010 |
Why?
|
Heterozygote | 1 | 2003 | 2798 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 3346 | 0.010 |
Why?
|
Animals | 2 | 2020 | 169335 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22379 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12253 | 0.010 |
Why?
|
Mice | 1 | 2013 | 82072 | 0.000 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_